A comparison of in vivo responses to cyclosporine, FK506, and rapamycin following allogeneic immune challenge.
Lorber
M I
MI
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06510.
Wilson
J H
JH
Harding
M W
MW
Gromkowski
S
S
Marks
W H
WH
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003524:Cyclosporins / Q000494:pharmacology; D007108:Immune Tolerance / Q000187:drug effects*; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007376:Interleukin-2 / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D011090:Polyenes / Q000494:pharmacology*; D020123:Sirolimus; D016559:Tacrolimus; D014184:Transplantation, Homologous / Q000276:immunology; D014185:Transplantation, Isogeneic / Q000276:immunology
D000900:Anti-Bacterial Agents; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D011090:Polyenes; D020123:Sirolimus; D016559:Tacrolimus